Qube Research & Technologies (QRT)’s Inspire Medical Systems INSP Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-66,184	Closed	-$3.41M	–	3770
2026 Q1	$3.41M	Buy	+66,184	New	+$4.63M	﹤0.01%	1858
2025 Q4	–	Sell	-82,810	Closed	-$6.14M	–	3864
2025 Q3	$6.14M	Buy	+82,810	New	+$8.38M	0.01%	1633
2024 Q2	–	Sell	-2,289	Closed	-$492K	–	4257
2024 Q1	$492K	Sell	2,289 -4,120	-64%	-$808K	﹤0.01%	2544
2023 Q4	$1.3M	Sell	6,409 -105,033	-94%	-$17M	﹤0.01%	1769
2023 Q3	$22.1M	Buy	111,442 +107,581	+2,786%	+$27.1M	0.06%	392
2023 Q2	$1.25M	Buy	+3,861	New	+$1.1M	﹤0.01%	1216
2022 Q1	–	Sell	-3,111	Closed	-$716K	–	2715
2021 Q4	$716K	Buy	3,111 +1,224	+65%	+$299K	0.01%	1379
2021 Q3	$439K	Sell	1,887 -1,655	-47%	-$345K	0.01%	1277
2021 Q2	$685K	Buy	+3,542	New	+$702K	0.01%	1118
2020 Q1	–	Sell	-6,911	Closed	-$513K	–	1397
2019 Q4	$513K	Buy	+6,911	New	+$444K	0.02%	941

Other funds holding INSP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Qube Research & Technologies (QRT)'s INSP Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of Inspire Medical Systems (INSP) in Q2 2026, closing a stake of 66,184 shares — an estimated $3.41M sold.

Qube Research & Technologies (QRT) first reported a position in INSP in Q4 2019 and held it in 10 quarters. The position peaked at $22.1M in Q3 2023. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

Qube Research & Technologies (QRT) reported no remaining Inspire Medical Systems position as of Q2 2026 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 66,184 Inspire Medical Systems shares in Q2 2026, an estimated $3.41M.
Qube Research & Technologies (QRT) first reported a position in Inspire Medical Systems in Q4 2019 and held it in 10 quarters.
Qube Research & Technologies (QRT)'s Inspire Medical Systems position peaked at $22.1M in Q3 2023.
275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.